PURE Bioscience, Inc.
PURE
$0.0675
$0.006711.02%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 25.58% | -29.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.58% | -29.68% | |||
| Cost of Revenue | 26.83% | -29.00% | |||
| Gross Profit | 24.67% | -30.15% | |||
| SG&A Expenses | -10.91% | -1.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.67% | -5.66% | |||
| Operating Income | 19.45% | -15.63% | |||
| Income Before Tax | 27.32% | -15.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.32% | -15.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.32% | -15.82% | |||
| EBIT | 19.45% | -15.63% | |||
| EBITDA | 19.53% | -22.80% | |||
| EPS Basic | 26.76% | -14.52% | |||
| Normalized Basic EPS | 28.89% | -18.42% | |||
| EPS Diluted | 26.76% | -14.52% | |||
| Normalized Diluted EPS | 28.89% | -18.42% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||